Accumed Radial

We are a preclinical medical device company in the structural heart space. We are developing a Transfemoral Mitral Valve Repair (TMVr) solution for a very common heart valve disease called Degenerative Mitral Regurgitation. Our TMVr solution uses pre-established techniques (transfemoral-transseptal delivery, annuloplasty, and chordal replacement) and is based on current surgical principles; we are reproducing proven surgical results without the need for surgery. Skarsgard is a Cardiovascular Surgeon and Clinical Associate Professor of Surgery at the University of British Columbia, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. Ledoux is a Business Specialist with over 23 years experience in Investment Banking, Corporate Management and Startups. Harrington is a Mechanical Engineer with over 8 years experience in engineering design and development, with a primary focus on cardiovascular implants. Saw is a Clinical Professor of Medicine at the University of British Columbia, and a Structural Interventional Cardiologist at the Vancouver General Hospital. Durkin is a Clinical Assistant Professor of Anaesthesiology at the University of British Columbia, and a member of the Section of Cardiovascular Anaesthesiology at Vancouver General Hospital.

Levin is a Heart Failure Cardiologist by training and a veteran in the field of biomedical engineering and cardiology. Chad has more than two decades of experience bringing innovative medical technologies to market. Brian Farley is a retired medical device executive and entrepreneur who built multiple successful medical technology companies from early-stage technology development, through commercialization and scaleup. Imran Eba is a founding partner at Action Potential Venture Capital, GSK’s corporate venture capital fund focused on investing in companies that pioneer bioelectronic medicines and other whitespace non-drug therapies. David Neustaedter, Ph.D., is a Venture Partner on the Medical Technologies team and joined the Firm in 2022. Andrew ElBardissi, M.D., is a Partner on the Medical Technologies team and joined the Firm in 2017. Reddy is a leading electrophysiologist, who focuses on developing and testing advanced therapies for cardiac arrhythmias and other conditions – including atrial fibrillation and ventricular tachycardias. Litwin is the Alicia Spaulding-Paolozzi Professor of Cardiology and Director of Cardiac Imaging at the Medical University of South Carolina.

Prior to AccurKardia, Juan was President of the largest non-emergency medical transportation company in Puerto Rico and a reformed former investment banker. Sadeq is a serial entrepreneur with successful companies in Data Analytics, Cloud Computing, and the Future of Work. Medtech leader with 20+ years of experience in medical device companies like Edwards Lifesciences, GE Healthcare, Vyaire Medical and Canon Medical. Strong healthcare services professional with a focus on cardiology, cardiovascular risk prediction, Big Data, and machine learning. Healthcare executive, advisor and investor with 20+ years of experience. Healthcare and finance leader with more than 25 years of experience. Naveen is the lead scientist and inventor our AccurKardia’s core technology. Tony is a seasoned healthcare executive with 10+ years of experience in remote cardiac monitoring and ECG interpretation.

We are advancing cardiac technology to ensure the best patient care and outcomes. We believe seamless, cloud-based technology can bring the human experience to medical AI – and the opportunities are groundbreaking. Partnering for a better tomorrowAmong our current trusted partnerships is a Top Ten US hospital system based in New York, a Top Five global pharma company and a leading Japanese pharma company. Entrepreneur with over 35 years of experience in the Medical Device industry as a product designer, developer, marketing & sales executive for Marquette Medical Systems, GE Healthcare, Mortara Instrument and Spaulding Clinical Research. Amanda is passionate about cardiac care and changing the world, one patient at a time. World-renowned cardiac drug safety expert with 35+ years of experience in cardiac care and research. From initial set-up to ongoing support, we’re committed to providing you with assistance round-the-clock.

Our vision is to transform the journey of cardiac patients, ensuring that every medical decision is data-driven.Leveraging Big Data, Machine Learning, and innovative methods, we aim to provide physicians with the necessary tools they need for precise diagnoses and tailored patient care. Our vision is to transform the cardiac patient pathway, ensuring that every medical decision is informed by data. Our goal is for every diagnosis to be precise and every treatment tailored to the individual. Our primary focus is on cardiovascular diseases, the world’s leading cause of death. Powerful Medical, backed by 28 leading cardiologists and steered by our prestigious Scientific Board, merges decades of expertise in patient care, clinical research, and medical devices. Previously founded several companies, including a US-based startup. With a decade-long track record in product and digital design, Viktor has been instrumental in the birth of several platforms within the healthcare and software sectors. With a decade of experience in marketing, Sarah established an all-female marketing agency dedicated to empowering female founders and small businesses.

Our mission is to serve the global community by creating life restoring medical devices that address acute and chronic unmet cardiopulmonary clinical needs. The original MC3 was founded in 1991 by Robert Bartlett M.D. Robert founded Avalon Laboratories in 1990 and grew it into the world’s largest surgical cannula OEM manufacturer before selling it in 2008. Rio Foster, VP Sales and Marketing, has medical device expertise focused on launching innovative products and therapy strategies through a deep understanding of customer-focused insights, business strategy, and process. Scott Merz, PhD., Chief Executive Officer and Co-Founder, has 25+ years of experience in medical device research, development, and business formation. Ted Chittenden, VP Operations, has vast experience with sterile disposables manufacturing and executive management, including previous leadership positions at Surge Cardiovascular, Cascade Engineering, and Medtronic. Martha’s experience includes regulatory submissions, risk management, quality planning, and technology transfer. Scott has 25+ years of experience in medical device research, development, and business formation.